AR006521A1 - Compuesto intermediario util, en la sintesis de inhibidores de la elastasa [s-(r'', s'')n-1-(1,3-benzodioxol-5-il)butil]-3,3-dietil-2-[4-[(4-metil-1-piperazinil)carbonil]fenoxil]-4-oxo-1-azetidin-carboxamida, procesos de sintesis de -r-alfa-propil-peperonil, amina - Google Patents
Compuesto intermediario util, en la sintesis de inhibidores de la elastasa [s-(r'', s'')n-1-(1,3-benzodioxol-5-il)butil]-3,3-dietil-2-[4-[(4-metil-1-piperazinil)carbonil]fenoxil]-4-oxo-1-azetidin-carboxamida, procesos de sintesis de -r-alfa-propil-peperonil, aminaInfo
- Publication number
- AR006521A1 AR006521A1 ARP970101148A ARP970101148A AR006521A1 AR 006521 A1 AR006521 A1 AR 006521A1 AR P970101148 A ARP970101148 A AR P970101148A AR P970101148 A ARP970101148 A AR P970101148A AR 006521 A1 AR006521 A1 AR 006521A1
- Authority
- AR
- Argentina
- Prior art keywords
- synthesis
- amine
- alpha
- benzodioxol
- piperazinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Compuesto intermediario útil en la síntesis de inhibidores de la elastasa [S-(R*,S*) N-1-(1,3-benzodioxol-5-il)butil] 3,3-dietil-2-[1-[(4-metil-1-piperazinil)carbonil]fenoxi]-4-oxo-1 azetinincarboxamida y proseco para la preparación de una R)-(alfa-propil-piperonil-amina de la fórmula I o unestereoisómero o sal del mismo. Con respecto al campo de aplicación, se han descrito vías de sintéticas para varios compuestos similares a la elastinaarriba mencionada, del tipo de la azetidinocarboxamida. Pero la R-alfa-propil- -piperonil-amina es una amina quiral que podría por tanto ser un intermediariosignificativo en el proceso de inhibición de la elastasa si se contara con una vía sintética a escala industrial.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1395596P | 1996-03-22 | 1996-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR006521A1 true AR006521A1 (es) | 1999-09-08 |
Family
ID=21762727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101148A AR006521A1 (es) | 1996-03-22 | 1997-03-21 | Compuesto intermediario util, en la sintesis de inhibidores de la elastasa [s-(r'', s'')n-1-(1,3-benzodioxol-5-il)butil]-3,3-dietil-2-[4-[(4-metil-1-piperazinil)carbonil]fenoxil]-4-oxo-1-azetidin-carboxamida, procesos de sintesis de -r-alfa-propil-peperonil, amina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5932749A (es) |
| EP (1) | EP0888329A1 (es) |
| JP (1) | JP2000506891A (es) |
| KR (1) | KR20000064735A (es) |
| CN (1) | CN1218463A (es) |
| AR (1) | AR006521A1 (es) |
| AU (1) | AU719633B2 (es) |
| BR (1) | BR9708233A (es) |
| CA (1) | CA2249401A1 (es) |
| CZ (1) | CZ295098A3 (es) |
| EA (1) | EA001207B1 (es) |
| EE (1) | EE9800299A (es) |
| HR (1) | HRP970165A2 (es) |
| IL (1) | IL126223A0 (es) |
| LT (1) | LT4540B (es) |
| LV (1) | LV12259B (es) |
| NO (1) | NO984344D0 (es) |
| NZ (1) | NZ331875A (es) |
| PL (1) | PL329070A1 (es) |
| SI (1) | SI9720023A (es) |
| SK (1) | SK127398A3 (es) |
| WO (1) | WO1997034887A1 (es) |
| ZA (1) | ZA972342B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5587299A (en) | 1998-08-31 | 2000-03-21 | Du Pont Pharmaceuticals Company | An efficient process for the preparation of a human leukocyte elastase inhibitor |
| CN100412062C (zh) * | 2001-09-12 | 2008-08-20 | 阿诺麦德股份有限公司 | 对映体纯的氨基取代稠合双环的合成 |
| JP2012512172A (ja) * | 2008-12-15 | 2012-05-31 | タイゲン バイオテクノロジー カンパニー，リミテッド | ピペリジン誘導体の立体選択的合成 |
| AR090100A1 (es) | 2012-02-21 | 2014-10-22 | Celgene Corp | Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina |
| US9126906B2 (en) | 2012-02-21 | 2015-09-08 | Celgene Corporation | Asymmetric synthetic processes for the preparation of aminosulfone compounds |
| WO2017106328A1 (en) | 2015-12-14 | 2017-06-22 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| CN109069486A (zh) | 2015-12-14 | 2018-12-21 | X4 制药有限公司 | 治疗癌症的方法 |
| EP3393468B1 (en) | 2015-12-22 | 2022-09-14 | X4 Pharmaceuticals, Inc. | Methods for treating immunodeficiency disease |
| WO2017177230A1 (en) | 2016-04-08 | 2017-10-12 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| JP6994767B2 (ja) | 2016-06-21 | 2022-01-14 | エックス４ ファーマシューティカルズ， インコーポレイテッド | Ｃｘｃｒ４阻害剤およびその使用 |
| WO2017223229A1 (en) | 2016-06-21 | 2017-12-28 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
| ES2870920T3 (es) | 2016-06-21 | 2021-10-28 | X4 Pharmaceuticals Inc | Inhibidores de CXCR4 y usos de los mismos |
| US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
| WO2023034510A1 (en) | 2021-09-01 | 2023-03-09 | ATAI Life Sciences AG | Synthesis of mdma or its optically active ( r)- or ( s)-mdma isomers |
| US20230109467A1 (en) * | 2021-09-17 | 2023-04-06 | ATAI Life Sciences AG | Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric salts |
| US11845736B2 (en) | 2021-10-01 | 2023-12-19 | Empathbio, Inc. | Prodrugs of MDMA, MDA, and derivatives thereof |
| US11912680B2 (en) | 2021-12-28 | 2024-02-27 | Empathbio, Inc. | Nitric oxide releasing prodrugs of MDA and MDMA |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3819438A1 (de) * | 1987-06-30 | 1989-01-19 | Basf Ag | Verfahren zur herstellung von optisch aktiven 1-arylethylaminen |
| IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
| US5149838A (en) * | 1991-09-20 | 1992-09-22 | Merck & Co., Inc. | Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents |
-
1997
- 1997-03-17 EE EE9800299A patent/EE9800299A/xx unknown
- 1997-03-17 EP EP97914876A patent/EP0888329A1/en not_active Ceased
- 1997-03-17 SK SK1273-98A patent/SK127398A3/sk unknown
- 1997-03-17 JP JP9533500A patent/JP2000506891A/ja active Pending
- 1997-03-17 IL IL12622397A patent/IL126223A0/xx unknown
- 1997-03-17 CA CA002249401A patent/CA2249401A1/en not_active Abandoned
- 1997-03-17 CZ CZ982950A patent/CZ295098A3/cs unknown
- 1997-03-17 PL PL97329070A patent/PL329070A1/xx unknown
- 1997-03-17 CN CN97194596A patent/CN1218463A/zh active Pending
- 1997-03-17 NZ NZ331875A patent/NZ331875A/xx unknown
- 1997-03-17 BR BR9708233-3A patent/BR9708233A/pt unknown
- 1997-03-17 WO PCT/US1997/003466 patent/WO1997034887A1/en not_active Application Discontinuation
- 1997-03-17 AU AU21968/97A patent/AU719633B2/en not_active Ceased
- 1997-03-17 SI SI9720023A patent/SI9720023A/sl unknown
- 1997-03-17 EA EA199800844A patent/EA001207B1/ru not_active IP Right Cessation
- 1997-03-17 KR KR1019980707470A patent/KR20000064735A/ko not_active Application Discontinuation
- 1997-03-18 ZA ZA972342A patent/ZA972342B/xx unknown
- 1997-03-21 HR HR60/013,955A patent/HRP970165A2/xx not_active Application Discontinuation
- 1997-03-21 US US08/822,996 patent/US5932749A/en not_active Expired - Fee Related
- 1997-03-21 AR ARP970101148A patent/AR006521A1/es unknown
-
1998
- 1998-09-18 NO NO984344A patent/NO984344D0/no unknown
- 1998-09-18 LT LT98-132A patent/LT4540B/lt not_active IP Right Cessation
- 1998-09-21 LV LVP-98-185A patent/LV12259B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1218463A (zh) | 1999-06-02 |
| NO984344L (no) | 1998-09-18 |
| AU719633B2 (en) | 2000-05-11 |
| CA2249401A1 (en) | 1997-09-25 |
| WO1997034887A1 (en) | 1997-09-25 |
| HRP970165A2 (en) | 1998-04-30 |
| IL126223A0 (en) | 1999-05-09 |
| LV12259B (en) | 1999-09-20 |
| SI9720023A (sl) | 1999-04-30 |
| EA001207B1 (ru) | 2000-12-25 |
| EE9800299A (et) | 1999-06-15 |
| SK127398A3 (en) | 1999-04-13 |
| EA199800844A1 (ru) | 1999-02-25 |
| BR9708233A (pt) | 2000-01-04 |
| LT4540B (lt) | 1999-08-25 |
| LV12259A (lv) | 1999-04-20 |
| NO984344D0 (no) | 1998-09-18 |
| EP0888329A1 (en) | 1999-01-07 |
| LT98132A (en) | 1999-03-25 |
| PL329070A1 (en) | 1999-03-15 |
| JP2000506891A (ja) | 2000-06-06 |
| NZ331875A (en) | 2000-01-28 |
| US5932749A (en) | 1999-08-03 |
| CZ295098A3 (cs) | 1999-03-17 |
| ZA972342B (en) | 1998-09-18 |
| AU2196897A (en) | 1997-10-10 |
| KR20000064735A (ko) | 2000-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR006521A1 (es) | Compuesto intermediario util, en la sintesis de inhibidores de la elastasa [s-(r'', s'')n-1-(1,3-benzodioxol-5-il)butil]-3,3-dietil-2-[4-[(4-metil-1-piperazinil)carbonil]fenoxil]-4-oxo-1-azetidin-carboxamida, procesos de sintesis de -r-alfa-propil-peperonil, amina | |
| DK1140918T3 (da) | Thrombininhibitorer | |
| BR9907300A (pt) | Inibidores do fator xa oxoaza-heterociclila substituìdos | |
| MX9701088A (es) | Composicion de recubrimiento inhibidora de corrosion para metales. | |
| IE851603L (en) | Antidepressant intermediate and new route | |
| TR200400238T4 (tr) | ''Perindopril tert-bütilamin tuzunun alfa kristalin şekli'' | |
| MY136141A (en) | Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors | |
| DK0810208T3 (da) | N-substituerede hydroxyethylamino sulfaminsyrederivater til anvendelse som inhibitorer af retrovirale proteaser | |
| YU41199A (sh) | Hinoksalindioni | |
| YU52000A (sh) | Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina | |
| ATE175404T1 (de) | Verbindungen zur hemmung der thrombin | |
| BR9713207A (pt) | Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz | |
| MXPA02012910A (es) | Amidas de acidobifenilcarboxilico, su preparacion y su uso como medicinas. | |
| BG107003A (en) | Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases | |
| AR044175A1 (es) | Compuestos de cefemo | |
| MY129094A (en) | Condensed polycyclic compounds | |
| PE20000725A1 (es) | Compuestos de alcoxipirrolidinona como inhibidores de proteasas | |
| MX9600816A (es) | Nuevos derivados triciclicos, su preparacion, su aplicacion a la preparacion de la colquicina y de la tiocolquicina, opticamente activas o racemicas, y de compuestos analogos o derivados e intermedios. | |
| ES2128031T3 (es) | Forma cristalina y polimorfica de (s,s,s)-n-(1-(2-carboxi-3-(n2-mesilisilamino)propil)-1-ciclopentilcarbonil)tirosina. | |
| DE69827614D1 (de) | Chinoxalindionen | |
| BR9912374A (pt) | Isoquinolinas como inibidores de urocinase | |
| DE60012208D1 (de) | Type 1 inhibitorkristalle als inhibitoren des natrium-protonen austauschs | |
| BR9809418A (pt) | Preparação de ácidos biarilcetocarboxìlicos enantiÈmeros puros | |
| HUP0203476A2 (en) | Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate, use thereof and pharmaceutical composition containing the same | |
| ECSP003854A (es) | Procedimientos y compuestos para la inhibicion de la mrp 1 |